Ohnishi K - Search Results

1

Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysis.

Kaneta Y, Kagami Y, Katagiri T, Tsunoda T, Jin-nai I, Taguchi H, Hirai H, Ohnishi K, Ueda T, Emi N, Tomida A, Tsuruo T, Nakamura Y, Ohno R. Kaneta Y, et al. Among authors: ohnishi k. Jpn J Cancer Res. 2002 Aug;93(8):849-56. doi: 10.1111/j.1349-7006.2002.tb01328.x. Jpn J Cancer Res. 2002. PMID: 12716460 Free PMC article.

2

Efficacy of the Shinki bioclean room for preventing infection in neutropenic patients.

Shinjo K, Takeshita A, Yanagi M, Yokota K, Hirano K, Suzuki M, Ohnishi K, Ohno R. Shinjo K, et al. Among authors: ohnishi k. J Adv Nurs. 2002 Feb;37(3):227-33. doi: 10.1046/j.1365-2648.2002.02095.x. J Adv Nurs. 2002. PMID: 11851792

3

Erythropoietin receptor in myelodysplastic syndrome and leukemia.

Takeshita A, Shinjo K, Naito K, Ohnishi K, Higuchi M, Ohno R. Takeshita A, et al. Among authors: ohnishi k. Leuk Lymphoma. 2002 Feb;43(2):261-4. doi: 10.1080/10428190290006026. Leuk Lymphoma. 2002. PMID: 11999556 Review.

4

Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia.

Takeshita A, Naito K, Shinjo K, Sahara N, Matsui H, Ohnishi K, Beppu H, Ohtsubo K, Horii T, Maekawa M, Inaba T, Ohno R. Takeshita A, et al. Among authors: ohnishi k. Cancer Genet Cytogenet. 2004 Jul 1;152(1):56-60. doi: 10.1016/j.cancergencyto.2003.10.002. Cancer Genet Cytogenet. 2004. PMID: 15193442

5

Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemia.

Ohnishi K, Ino A, Kishimoto Y, Usui N, Shimazaki C, Ohtake S, Taguchi H, Yagasaki F, Tomonaga M, Hotta T, Ohno R; Japan Adult Leukemia Study Group. Ohnishi K, et al. Int J Hematol. 2004 May;79(4):345-53. doi: 10.1532/ijh97.03160. Int J Hematol. 2004. PMID: 15218963 Clinical Trial.

6

Shigeno K, Yoshida H, Pan L, Luo JM, Fujisawa S, Naito K, Nakamura S, Shinjo K, Takeshita A, Ohno R, Ohnishi K. Shigeno K, et al. Among authors: ohnishi k. Cancer Lett. 2004 Sep 15;213(1):11-20. doi: 10.1016/S0304-3835(03)00442-7. Cancer Lett. 2004. PMID: 15312679

7

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.

Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R. Morishima Y, et al. Among authors: ohnishi k. Int J Hematol. 2004 Oct;80(3):261-6. doi: 10.1532/ijh97.04074. Int J Hematol. 2004. PMID: 15540902 Clinical Trial.

8

Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment.

Shinjo K, Takeshita A, Sahara N, Kobayashi M, Nakamura S, Shigeno K, Naito K, Maekawa M, Ohnishi K, Ohno R. Shinjo K, et al. Among authors: ohnishi k. Intern Med. 2005 Aug;44(8):818-24. doi: 10.2169/internalmedicine.44.818. Intern Med. 2005. PMID: 16157979 Free article.

9

Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.

Shigeno K, Naito K, Sahara N, Kobayashi M, Nakamura S, Fujisawa S, Shinjo K, Takeshita A, Ohno R, Ohnishi K. Shigeno K, et al. Among authors: ohnishi k. Int J Hematol. 2005 Oct;82(3):224-9. doi: 10.1532/IJH97.05044. Int J Hematol. 2005. PMID: 16207595 Clinical Trial.

10

Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.

Fujisawa S, Ohno R, Shigeno K, Sahara N, Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y, Hashimoto H, Kinoshita K, Shimoya M, Kaise T, Ohnishi K. Fujisawa S, et al. Among authors: ohnishi k. Cancer Chemother Pharmacol. 2007 Mar;59(4):485-93. doi: 10.1007/s00280-006-0288-4. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,409 results

Search Page